Wellbutrin SR
$ 62,00 – $ 299,00Price range: $ 62,00 through $ 299,00
Xalatan
$ 74,00 – $ 405,00Price range: $ 74,00 through $ 405,00
Womenra
$ 50,00 – $ 300,00Price range: $ 50,00 through $ 300,00
Womenra is a specialized medication formulated to address female sexual interest and arousal disorder by enhancing physiological response. It contains Sildenafil Citrate, which works by increasing blood flow to the pelvic region to boost sensitivity during intimate moments. This treatment helps women achieve greater satisfaction by supporting natural lubrication and heightening physical sensations. Many users find that it effectively reduces the time needed to reach a peak state of arousal, making intimacy more fulfilling. Designed specifically for women’s unique needs, Womenra offers a reliable solution for revitalizing sexual health and confidence.
Active substance: Sildenafil
SKU:
Womenra
Category: Woman's Health
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Womenra contains sildenafil citrate, an active compound belonging to the class of phosphodiesterase type 5 (PDE5) inhibitors. In the United States, medications containing sildenafil are prescription-only drugs dispensed under strict federal and state regulations. While PDE5 inhibitors are well-established for male erectile dysfunction, use of sildenafil formulations in women for female sexual arousal disorders is generally considered off-label and requires direct supervision by a licensed healthcare provider.
Clinical evaluation is mandatory prior to initiating treatment with sildenafil to evaluate underlying cardiovascular status, hormone balance, and potential pharmacological interactions. Patients should obtain this medication only through legitimate pharmacies with a valid prescription from a licensed healthcare provider.
| Property | Details |
|---|---|
| Active ingredient (INN) | Sildenafil citrate |
| Therapeutic class | Phosphodiesterase type 5 (PDE5) inhibitor |
| Dosage form | Oral tablet |
| Route of administration | Oral |
| Prescription status | Prescription (Rx) only |
| Main side effect | Headache, flushing, nasal congestion |
Clinical Profile and Usage Information
What it’s used for
In clinical practice within the United States, sildenafil citrate is primarily FDA-approved for male erectile dysfunction and pulmonary arterial hypertension. When prescribed for female patients, Womenra is utilized off-label to address symptoms of female sexual arousal disorder (FSAD) or personal distress related to sexual dysfunction. Off-label prescribing means that while the FDA has not formally approved sildenafil for this specific female indication, a licensed practitioner may determine that its physiological actions could benefit a specific patient based on clinical evidence and individual medical history. Patients must discuss potential risks and expected outcomes with their prescribing clinician before starting therapy.
Mechanism of action
The mechanism of action of sildenafil citrate involves the selective inhibition of the cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) enzyme. By inhibiting PDE5, the drug prevents the degradation of cGMP in vascular smooth muscle cells. Increased levels of cGMP lead to smooth muscle relaxation and enhanced arterial blood flow to pelvic tissues, including the clitoris and labia. This physiological response facilitates local vascular engorgement and fluid lubrication during sexual stimulation. The drug does not act as a direct aphrodisiac and requires natural physiological or psychological sexual stimulation to produce its physiological effects.
What happens in the body
Following oral administration, sildenafil citrate is rapidly absorbed from the gastrointestinal tract. Peak plasma concentration (Cmax) is generally reached within 30 to 120 minutes (median time of approximately 60 minutes) when taken in a fasted state. The drug undergoes extensive hepatic metabolism, predominantly via the cytochrome P450 3A4 (CYP3A4) pathway, with a minor contribution from the CYP2C9 enzyme. Its primary circulating metabolite, N-desmethyl sildenafil, possesses PDE selectivity similar to the parent compound but demonstrates lower potency. The mean terminal elimination half-life of sildenafil ranges between 3 to 5 hours, with excretion occurring mainly as metabolites in the feces and to a lesser extent in the urine.
Dosing schedule
The dosing schedule for Womenra is individualized by the prescribing healthcare professional based on therapeutic goal, tolerability, and underlying patient health. The tablet is administered orally with a glass of water, typically 30 to 60 minutes prior to anticipated sexual activity. Only one dose should be administered within a 24-hour period. Dosing frequency and strength may be adjusted by a physician for patients with mild to moderate renal or hepatic impairment, or for individuals taking concurrent medications that alter hepatic enzyme clearance. Strict adherence to the prescribed dosing regimen is required to minimize the risk of adverse cardiovascular events.
Compatibility with other medicines
Co-administration of sildenafil with organic nitrates in any form (such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) or nitric oxide donors (such as amyl nitrate or nitrite) is strictly contraindicated due to the risk of severe, potentially fatal hypotension. Concomitant administration with soluble guanylate cyclase stimulators, such as riociguat, is also contraindicated. Co-administration with strong CYP3A4 inhibitors (including ketoconazole, itraconazole, clarithromycin, and HIV protease inhibitors) significantly increases systemic exposure to sildenafil, necessitating dose reduction. Furthermore, concurrent use with alpha-blockers or antihypertensive agents requires caution to prevent additive blood-pressure-lowering effects.
Adverse reactions
Adverse reactions associated with sildenafil citrate are primarily attributable to its vasodilatory properties. The most frequently reported adverse events include headache, facial flushing, dyspepsia, nasal congestion, dizziness, and mild, transient visual disturbances (such as altered color perception, cyanopsia, or blurred vision). Less common but serious side effects include severe hypotension, syncope, and sudden decreases in visual or auditory acuity. Non-arteritic anterior ischemic optic neuropathy (NAION) and sudden sensorineural hearing loss have been reported in post-marketing surveillance for PDE5 inhibitors. Patients experiencing severe hypersensitivity reactions, persistent dizziness, or chest pain must seek medical care immediately.
What you may notice early on
During initial doses, individuals may notice mild physiological changes within one hour of administration, such as slight facial warmth or transient nasal fullness. Therapeutic physiological responses, including increased pelvic blood flow and heightened tissue sensitivity, manifest only when combined with adequate sexual stimulation. If mild headache or indigestion occurs early in treatment, these symptoms often subside as systemic concentrations decline. Patients should monitor their physical response during early use and report any persistent discomfort to their prescriber.
If you skip a dose
Because Womenra is prescribed for use on an as-needed basis prior to sexual activity rather than on a continuous daily schedule, missed doses do not disrupt a structured therapeutic routine. Patients should take the medication only when planned and should never take a double dose to make up for a skipped opportunity. Taking more than the prescribed amount increases the probability of drug toxicity and severe side effects.
What to avoid while taking it
Patients taking Womenra should avoid consuming high-fat meals immediately before dosing, as dietary lipids slow gastric emptying and delay systemic drug absorption. Concomitant intake of substantial quantities of alcohol should be avoided, as ethanol possesses independent vasodilatory effects that may exacerbate orthostatic dizziness, lightheadedness, and low blood pressure. Additionally, grapefruit and grapefruit juice should be avoided because compounds in grapefruit inhibit intestinal CYP3A4 enzymes, potentially leading to elevated plasma levels of sildenafil and heightened risk of toxicity.
Storage and expiration
Womenra tablets must be stored at controlled room temperature, ideally between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). The medication should be kept in its original packaging to protect the contents from moisture, direct heat, and excessive light. Store the product securely away from children and pets. Do not use tablets past the expiration date printed on the container, and dispose of unused medication according to federal and state pharmaceutical waste guidelines.
Important precautions
Prior to prescribing sildenafil, a thorough cardiovascular assessment is recommended, as sexual activity carries a degree of cardiac risk. Caution is required in patients with pre-existing cardiovascular conditions, severe hepatic impairment, severe renal impairment, or severe anatomical deformities. The safety of sildenafil has not been established in patients with hereditary degenerative retinal disorders, such as retinitis pigmentosa. In elderly patients, decreased hepatic or renal clearance may elevate plasma levels, requiring careful clinical monitoring and conservative initial dosing.
Frequently Asked Questions
Is sildenafil citrate FDA-approved for female sexual arousal disorder?
No. In the United States, sildenafil citrate is approved by the FDA primarily for male erectile dysfunction and pulmonary arterial hypertension. Use of sildenafil in female patients for sexual arousal disorders is considered an off-label application. Licensed healthcare prescribers may evaluate individual circumstances to determine if off-label treatment is medically appropriate.
Can Womenra be taken simultaneously with nitrate medications?
No. Co-administration of sildenafil with organic nitrates (such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) or recreational nitrates (“poppers”) is strictly contraindicated. Combined use can precipitate a sudden, life-threatening drop in blood pressure (severe hypotension) and cardiovascular collapse.
Does food affect how quickly the medication takes effect?
Yes. Taking Womenra with a high-fat meal can delay the rate of gastrointestinal absorption, resulting in a delayed onset of action and lower peak blood concentrations compared to administration in a fasted state or after a light meal.
What should be done if an adverse reaction occurs?
Mild symptoms like transient headaches or flushing usually resolve as the drug clears the body. However, if severe symptoms develop–such as chest pain, sudden vision changes, severe dizziness, or signs of an allergic reaction like facial swelling–seek emergency medical assistance immediately.
This material is educational. Only a licensed prescriber can determine whether a medication is appropriate for you. In accordance with FDA requirements.
Additional information
| Dosage |
100mg |
|---|---|
| Package |
10 pills ,20 pills ,30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Alesse
$ 65,00 – $ 208,00Price range: $ 65,00 through $ 208,00
Active substance: ethinyloestradiol, Levonorgestrel
More Details
This product has multiple variants. The options may be chosen on the product page
Aygestin
$ 58,00 – $ 290,00Price range: $ 58,00 through $ 290,00
Active substance: Norethindrone
More Details
This product has multiple variants. The options may be chosen on the product page
Careprost
$ 42,00 – $ 367,00Price range: $ 42,00 through $ 367,00
Active substance: Bimatoprost
More Details
This product has multiple variants. The options may be chosen on the product page
Clomid
$ 45,00 – $ 255,00Price range: $ 45,00 through $ 255,00
Active substance: Clomiphene
More Details
This product has multiple variants. The options may be chosen on the product page
Cycrin
$ 52,00 – $ 347,00Price range: $ 52,00 through $ 347,00
Active substance: Medroxyprogesterone
More Details
This product has multiple variants. The options may be chosen on the product page
Diane 35
$ 16,00 – $ 46,00Price range: $ 16,00 through $ 46,00
Active substance: Cyproterone Acetate, Ethyl Estradiol
More Details
This product has multiple variants. The options may be chosen on the product page
Estriol
$ 64,00 – $ 137,00Price range: $ 64,00 through $ 137,00
Active substance: Estriol
More Details
This product has multiple variants. The options may be chosen on the product page
Female Cialis
$ 20,00 – $ 340,00Price range: $ 20,00 through $ 340,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
